1800-121-1711 
Donate 
Book an Appointment
Quick Enquiry
Patient Portal 
Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in the lymphatic system, which is part of the body's immune system. Unlike Hodgk...
Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in the lymphatic system, which is part of the body's immune system. Unlike Hodgkin lymphoma, NHL comprises a diverse group of cancers that arise from abnormal lymphocytes, a type of white blood cell. The exact cause of NHL is not fully understood, but certain risk factors may increase its likelihood, including a weakened immune system, certain infections such as the Epstein-Barr virus and human T-cell leukemia/lymphoma virus (HTLV-1), exposure to certain chemicals or toxins, and certain autoimmune diseases and immunodeficiency disorders. Symptoms of NHL may vary depending on the subtype and location of the cancer but commonly include painless swelling of lymph nodes, fever, night sweats, unexplained weight loss, fatigue, and itching. Diagnosing NHL typically involves a combination of imaging tests such as CT scans and PET scans, as well as a lymph node biopsy to examine the abnormal cells under a microscope. Treatment options for NHL depend on factors such as the subtype and stage of the disease, as well as the patient's overall health. Options may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell transplantation, or a combination of these approaches. Supportive care and rehabilitation play crucial roles in managing symptoms, preventing complications, and supporting the patient's overall well-being throughout the treatment process. While the prognosis for NHL can vary depending on several factors, ongoing research and advancements in treatment offer hope for improved outcomes and quality of life for individuals affected by this condition.
Facing a cancer diagnosis can be overwhelming. Our brief guide offers insights into various types of cancer, detailing symptoms, detection, treatments, and post-treatment care, providing support and clarity along your journey.
Risk factors for non-Hodgkin lymphoma (NHL) include a weakened immune system, certain infections such as Epstein-Barr virus and human T-cell leukemia/lymphoma virus (HTLV-1), exposure to certain chemicals or toxins, autoimmune diseases, and immunodeficiency disorders. While these factors may increase the risk, the majority of individuals with NHL do not have any identifiable risk factors.
Signs and symptoms of non-Hodgkin lymphoma may include painless swelling of lymph nodes, typically in the neck, armpits, or groin, fever, night sweats, unexplained weight loss, fatigue, itching, and abdominal pain or swelling. These symptoms may vary depending on the subtype and location of the cancer and can mimic other conditions, highlighting the importance of seeking medical evaluation for any unusual symptoms.
Diagnosing non-Hodgkin lymphoma typically involves a combination of imaging tests such as CT scans and PET scans, as well as a lymph node biopsy to examine the abnormal cells under a microscope. Blood tests may also be performed to assess blood cell counts and other markers of disease activity. Additional tests may be conducted to determine the subtype and stage of the disease.
Treatment for non-Hodgkin lymphoma depends on factors such as the subtype and stage of the disease, as well as the patient's overall health. Options may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell transplantation, or a combination of these approaches. The choice of treatment is often individualized based on the specific characteristics of the cancer and the patient's preferences.
Supportive care and rehabilitation are essential components of treatment for non-Hodgkin lymphoma, aiming to manage symptoms, prevent complications, and support the patient's overall well-being. This may include medications to manage pain and side effects of treatment, nutritional support, psychological counseling, and physical therapy.
Preventing non-Hodgkin lymphoma may not be entirely possible due to its complex nature and often unknown causes. However, maintaining a healthy lifestyle, avoiding exposure to known risk factors such as chemicals and toxins, and seeking prompt medical evaluation for any suspicious symptoms may help reduce the risk.
Non-Hodgkin lymphoma is a heterogeneous group of cancers that requires prompt diagnosis and comprehensive treatment. With advances in diagnosis and treatment, the prognosis for individuals with NHL has improved significantly in recent years. Ongoing research and advancements in treatment are needed to further improve outcomes and quality of life for individuals affected by this condition. By understanding the risk factors, recognizing the signs and symptoms, and seeking timely medical care, individuals can take proactive steps to address this disease and improve their chances of successful treatment and long-term survival.
Non-Hodgkin Lymphoma is a type of cancer that originates in the lymphatic system, involving abnormal growth of lymphocytes, a type of white blood cell.
Symptoms may include swollen lymph nodes, fever, night sweats, unexplained weight loss, fatigue, and itching.
Diagnosis involves a combination of physical examination, imaging tests such as CT scans and PET scans, biopsy of affected lymph nodes or tissues, and sometimes bone marrow biopsy.
The exact cause is often unknown, but factors such as genetics, immune system deficiencies, infections (e.g., Epstein-Barr virus, HIV), and exposure to certain chemicals or radiation may increase the risk.
Non-Hodgkin Lymphoma includes various subtypes, such as diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma, among others. Each subtype has distinct characteristics and treatment approaches.
Non-Hodgkin Lymphoma is staged based on the extent of the disease, including the number and location of affected lymph nodes, involvement of other organs, and whether it has spread to bone marrow or other tissues.
Treatment may include chemotherapy, immunotherapy, radiation therapy, targeted therapy, stem cell transplantation, or a combination of these approaches, depending on the subtype and stage of the disease.
Many cases of Non-Hodgkin Lymphoma are treatable and even curable, especially when diagnosed early and treated appropriately. However, the prognosis varies depending on factors such as the subtype, stage, and response to treatment.
Side effects may include fatigue, nausea, hair loss, increased risk of infection, and long-term effects such as infertility or secondary cancers. However, side effects vary depending on the type and intensity of treatment.
Yes, there are ongoing clinical trials evaluating new treatments, combination therapies, and supportive care approaches for Non-Hodgkin Lymphoma. Eligible patients may have the opportunity to participate in these trials.
Yes, Non-Hodgkin Lymphoma can recur even after successful treatment. Regular follow-up appointments and surveillance tests are essential to monitor for any signs of recurrence.
Offer emotional support, accompany them to appointments, assist with daily tasks, provide distractions, encourage self-care, and be a good listener.
Some patients may find relief from symptoms through complementary therapies such as acupuncture, massage therapy, or relaxation techniques. It's essential to discuss these options with healthcare providers.
You can ask your primary care physician for a referral to a hematologist-oncologist or a medical oncologist who specializes in treating Non-Hodgkin Lymphoma.
Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking and excessive alcohol consumption, may help support overall well-being during treatment.
Every contribution is a vital step forward in our battle against cancer, bringing hope and healing to countless lives. Join us in making a difference today.
Donate Now
